MCF Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $74.3K | Hold |
167
| – | – | ﹤0.01% | 353 |
|
|
2025
Q1 | $81K | Sell |
167
-7
| -4% | -$3.39K | 0.01% | 338 |
|
|
2024
Q4 | $70.1K | Hold |
174
| – | – | ﹤0.01% | 355 |
|
|
2024
Q3 | $80.9K | Sell |
174
-2
| -1% | -$930 | 0.01% | 329 |
|
|
2024
Q2 | $82.5K | Buy |
176
+18
| +11% | +$8.44K | 0.01% | 322 |
|
|
2024
Q1 | $66K | Sell |
158
-5
| -3% | -$2.09K | 0.01% | 338 |
|
|
2023
Q4 | $66.3K | Buy |
163
+7
| +4% | +$2.85K | 0.01% | 339 |
|
|
2023
Q3 | $54.2K | Buy |
156
+110
| +239% | +$38.3K | ﹤0.01% | 345 |
|
|
2023
Q2 | $16.2K | Hold |
46
| – | – | ﹤0.01% | 503 |
|
|
2023
Q1 | $14.5K | Buy |
46
+39
| +557% | +$12.3K | ﹤0.01% | 521 |
|
|
2022
Q4 | $2.02K | Hold |
7
| – | – | ﹤0.01% | 677 |
|
|
2022
Q3 | $2K | Hold |
7
| – | – | ﹤0.01% | 698 |
|
|
2022
Q2 | $2K | Hold |
7
| – | – | ﹤0.01% | 648 |
|
|
2022
Q1 | $2K | Buy |
+7
| New | +$2K | ﹤0.01% | 662 |
|
|
2021
Q4 | – | Sell |
-12
| Closed | -$2K | – | 668 |
|
|
2021
Q3 | $2K | Buy |
+12
| New | +$2K | ﹤0.01% | 640 |
|